Palm Therapeutics, Inc.

San Diego, CA

UEI
RXJNLF4A6MB8
CAGE
89WC6
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3210 Merryfield Row, San Diego, CA 92121, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A small molecule enzyme replacement for the treatment of CLN1 R43NS122619 National Institute of Neurological Disorders and Stroke (NIH) $1,401,273
Targeted depalmitoylation for the treatment of nras-driven melanoma R43CA250702 National Cancer Institute (NIH) $857,756

Quick answers

Is Palm Therapeutics, Inc. registered in SAM.gov?

Yes. Palm Therapeutics, Inc.'s SAM.gov registration is active through February 16, 2027.

What is Palm Therapeutics, Inc.'s most recent federal award?

Palm Therapeutics, Inc.'s most recent federal grant award is A small molecule enzyme replacement for the treatment of CLN1 (R43NS122619), from National Institute of Neurological Disorders and Stroke (NIH), on August 15, 2021.

On GovTribe

See Palm Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login